- Trials with a EudraCT protocol (4)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
4 result(s) found for: Sweetness.
Displaying page 1 of 1.
EudraCT Number: 2012-004864-24 | Sponsor Protocol Number: COPD-1 | Start Date*: 2013-07-09 |
Sponsor Name:Bionorica SE | ||
Full Title: Randomized, placebo-controlled, double-blind, cross-over trial with Bronchipret and Sinupret to evaluate acceleration of mucociliary clearance (MCC) | ||
Medical condition: PR1: Acceleration of mucociliary clearance as a therapeutic effect when treating inflammation of the nasal sinuses PR2: Acceleration of mucociliary clearance as a therapeutic effect when treating ... | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: BE (Completed) | ||
Trial results: View results |
EudraCT Number: 2011-004901-25 | Sponsor Protocol Number: MEK115892 | Start Date*: 2012-07-25 |
Sponsor Name:GlaxoSmithKline Research and Development Ltd | ||
Full Title: An Open-Label, Two-Period, Randomized, Crossover Study to Assess the Relative Bioavailability of GSK1120212 Tablet Formulation and the GSK1120212 Pediatric Oral Solution Formulation Following Si... | ||
Medical condition: GSK1120212 is currently being developed for a number of solid tumors, including metastatic BRAF-mutant melanoma (Phase 3), pancreatic cancer (Phase 2) and non small cell lung cancer (Phase 2), and ... | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: Outside EU/EEA | ||
Trial results: View results |
EudraCT Number: 2015-005732-18 | Sponsor Protocol Number: DU176b-A-U157 | Start Date*: 2016-06-29 | ||||||||||||||||
Sponsor Name:Daiichi Sankyo , Inc. | ||||||||||||||||||
Full Title: A Phase 1, Open-Label, Single-dose, Non-randomized Study to Evaluate Pharmacokinetics and Pharmacodynamics of Edoxaban in Pediatric Patients | ||||||||||||||||||
Medical condition: Edoxaban is being investigated for use in pediatric patients who may require anticoagulation therapy. | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | |||||||||||||||||
Trial protocol: ES (Completed) FR (Ongoing) IT (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2013-003596-35 | Sponsor Protocol Number: MEK116540 | Start Date*: 2015-12-15 | |||||||||||
Sponsor Name:Novartis Pharma Services AG | |||||||||||||
Full Title: An Open-Label, Dose-Escalation, Phase I/II Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity of the MEK Inhibitor Trametinib in Children and Adolescents Subj... | |||||||||||||
Medical condition: Children and Adolescents with Cancers Harboring V600 mutations | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) FR (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.